American Well (AMWL) to Release Quarterly Earnings on Wednesday

American Well (NYSE:AMWL) is expected to release its Q4 2025 results before the market opens on Wednesday, February 11th. Analysts expect American Well to post earnings of ($1.59) per share and revenue of $52.7070 million for the quarter. Individuals can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Wednesday, February 11, 2026 at 4:00 PM ET.

American Well (NYSE:AMWL) last released its quarterly earnings data on Tuesday, November 4th. The company reported ($1.74) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.83) by $0.09. American Well had a negative return on equity of 39.80% and a negative net margin of 42.80%.The company had revenue of $56.29 million for the quarter, compared to analyst estimates of $54.56 million. On average, analysts expect American Well to post $-9 EPS for the current fiscal year and $-6 EPS for the next fiscal year.

American Well Stock Down 5.0%

Shares of NYSE AMWL opened at $4.35 on Wednesday. The company has a market cap of $71.21 million, a P/E ratio of -0.60 and a beta of 1.36. American Well has a 52 week low of $3.71 and a 52 week high of $12.95. The business has a 50-day simple moving average of $4.61 and a two-hundred day simple moving average of $5.66.

Insiders Place Their Bets

In other American Well news, insider Dmitry Zamansky sold 6,243 shares of the company’s stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $4.85, for a total value of $30,278.55. Following the completion of the sale, the insider owned 191,468 shares of the company’s stock, valued at $928,619.80. This represents a 3.16% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders sold a total of 14,633 shares of company stock worth $67,972 in the last quarter. Company insiders own 12.80% of the company’s stock.

Institutional Investors Weigh In On American Well

A number of hedge funds have recently made changes to their positions in AMWL. JPMorgan Chase & Co. grew its stake in shares of American Well by 16.5% in the second quarter. JPMorgan Chase & Co. now owns 14,720 shares of the company’s stock worth $131,000 after purchasing an additional 2,081 shares during the last quarter. Headlands Technologies LLC purchased a new stake in American Well in the 2nd quarter worth approximately $39,000. Two Sigma Investments LP grew its position in shares of American Well by 22.6% in the 3rd quarter. Two Sigma Investments LP now owns 46,329 shares of the company’s stock worth $285,000 after buying an additional 8,553 shares during the last quarter. Engineers Gate Manager LP purchased a new position in shares of American Well during the second quarter valued at approximately $101,000. Finally, Prelude Capital Management LLC bought a new position in shares of American Well during the third quarter valued at approximately $86,000. 56.05% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Morgan Stanley cut their price objective on shares of American Well from $10.50 to $6.00 and set an “equal weight” rating for the company in a research report on Thursday, December 18th. Wells Fargo & Company lowered their target price on shares of American Well from $12.00 to $9.00 and set an “overweight” rating on the stock in a research note on Wednesday, November 5th. Stifel Nicolaus reduced their price target on shares of American Well from $8.00 to $6.00 and set a “hold” rating for the company in a research report on Wednesday, November 5th. Wall Street Zen downgraded American Well from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of American Well in a research note on Wednesday, January 21st. One equities research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $7.58.

American Well Company Profile

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.